Carl E Dahl House at Evergreen Grove CoOccurring Enhanced (COE)

Carl E Dahl House at Evergreen Grove CoOccurring Enhanced (COE)

Services:
Ancillary Services
• Suicide prevention services
• Mental health services
• Transportation assistance
• Case management service
• Social skills development
• Integrated primary care services

Type of Care

• Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
• Substance use treatment

Treatment Approaches

• 12-step facilitation
• Community reinforcement plus vouchers
• Telemedicine/telehealth therapy
• Motivational interviewing
• Brief intervention
• Cognitive behavioral therapy
• Anger management
• Trauma-related counseling
• Contingency management/motivational incentives
• Relapse prevention
• Substance use disorder counseling
• Matrix Model

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Residential/24-hour residential
• Long-term residential

Transitional Services

• Outcome follow-up after discharge
• Discharge Planning
• Aftercare/continuing care
• Naloxone and overdose education

Testing

• Breathalyzer or blood alcohol testing
• TB screening
• Drug or alcohol urine screening

Payment/Insurance/Funding Accepted

• Cash or self-payment
• Medicare
• State-financed health insurance plan other than Medicaid
• Federal, or any government funding for substance use treatment programs

Type of Alcohol Use Disorder Treatment

• Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere

Assessment/Pre-treatment

• Comprehensive substance use assessment
• Screening for tobacco use
• Screening for mental disorders
• Screening for substance use

License/Certification/Accreditation

• State Substance use treatment agency
• State department of health

Facility Vaping Policy

• Vaping permitted in designated area

Special Programs/Groups Offered

• Adult men
• Clients with co-occurring mental and substance use disorders

Age Groups Accepted

• Young Adults
• Adults

Pharmacotherapies

• Buprenorphine sub-dermal implant
• Non-nicotine smoking/tobacco cessation
• Buprenorphine with naloxone
• Medications for HIV treatment
• Lofexidine
• Medication for mental disorders
• Medications for Hepatitis C treatment
• Naltrexone (oral)
• Buprenorphine without naloxone
• Nicotine replacement
• Buprenorphine (extended-release, injectable)
• Disulfiram
• Acamprosate (Campral®)
• Clonidine
• Naltrexone (extended-release, injectable)

Facility Operation (e.g., Private, Public)

• Private non-profit organization

Facility Smoking Policy

• Smoking permitted in designated area

Opioid Medications used in Treatment

• Buprenorphine used in Treatment
• Naltrexone used in Treatment

Education and Counseling Services

• Substance use disorder education
• HIV or AIDS education, counseling, or support
• Individual counseling
• Health education services other than HIV/AIDS or hepatitis
• Hepatitis education, counseling, or support
• Smoking/vaping/tobacco cessation counseling
• Group counseling

Recovery Support Services

• Recovery coach
• Self-help groups
• Housing services
• Mentoring/peer support
• Employment counseling or training
• Assistance with obtaining social services

Gender Accepted

• Male

External Source of Medications Used for Alcohol Use Disorder Treatment

• No formal relationship with prescribing entity
• In-network prescribing entity
• Other contracted prescribing entity

Type of Opioid Treatment

• Prescribes buprenorphine
• Relapse prevention with naltrexone
• Accepts clients using MAT but prescribed elsewhere
• Buprenorphine maintenance

External Opioid Medications Source

• Other contracted prescribing entity